Twist Bioscience Corporation
TWST | NASDAQ
$145.80
-$6.98 (-4.57%)
Nov 2, 2026, 9:46 AM ET · Market open
Market Data
Market Cap $9.6B
Enterprise Value $9.98B
Beta 2.22
Average Volume 2.11M
Shares Outstanding (Diluted) 62.4M
Shares Change YoY 2.03%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US90184D1000
Price Performance
Price Change 1M -22.7%
Price Change 3M 44.3%
Price Change 6M 159.5%
Price Change YTD 359.6%
Price Change 1Y 361.8%
Price Change 3Y 681.4%
Price Change 5Y 8.5%
1M CAGR (ann.) -8.5%
1Y CAGR (ann.) 374.3%
5Y CAGR (ann.) 5.4%
All-Time CAGR 34.8%
Valuation
PE Ratio -68.82
Forward PE N/A
PEG Ratio 1.05
Forward PEG 1.77
PS Ratio 23.29
Forward PS 18.30
PB Ratio 22.56
P/FCF Ratio -108.01
P/Adj. FCF Ratio -63.02
P/OCF Ratio -179.74
EV/Sales 23.12
EV/EBIT -74.97
EV/EBITDA -92.63
EV/FCF -107.22
Earnings Yield -1.4%
FCF Yield -0.9%
Adj. FCF Yield -1.6%
Financial Health
Net Cash $158.21M
Total Debt $93.59M
Cash & Short-Term Investments $166.84M
Total Assets $672.44M
Current Ratio 2.67
Quick Ratio 2.38
Debt / Equity Ratio 0.21
Debt / EBITDA -0.87
Debt / FCF -1.01
OCF / Debt -0.57
Interest Coverage 0.00
Altman Z-Score 23.99
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 52.0%
Operating Profit Margin -31.9%
EBITDA Margin -25.0%
Net Profit Margin -31.7%
FCF Margin -21.6%
Adj. FCF Margin -37.0%
SBC / Revenue 15.4%
SBC Impact (per share) -71.4%
Returns
Return on Assets -20.3%
Return on Equity -29.9%
Return on Invested Capital -24.6%
Return on Capital Employed -24.9%
Return on Tangible Assets -23.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 22.4%
Revenue CAGR 5Y 27.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 32.0%
EPS CAGR 5Y 18.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y -11.5%
FCF CAGR 5Y 31.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 32.4%
Revenue Growth Next 3Y 21.4%
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.38
EPS Growth Est (next Q) -14.6%
Revenue Est (next Q) $123.59M
Revenue Growth Est (next Q) 24.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $153.70
Price Target Upside 0.6%
Cash Flow
Operating Cash Flow $-53.07M
Free Cash Flow $-93.12M
Adj. Free Cash Flow $-159.59M
FCF Per Share -$1.49
OCF Per Share -$0.85
OCF/S Ratio -12.3%
Income Statement
Revenue $431.8M
Gross Profit $224.39M
Operating Income $-137.77M
EBITDA $-107.79M
Net Income $-136.72M
EPS (Diluted) -$2.22
Revenue / Employee $441.06K
Profit / Employee $-139.65K
Employees 979
Add to Watchlist
Select watchlists to add or remove TWST